Portfolio Alerts Watch List Cart

Healthcare

Refine Search


Product Compare (0)
S
Sandu Pharmaceuticals Ltd
Score 48/100• Decent
Sandu Pharmaceuticals has a decent growth outlook but faces challenges in valuation and execution risks.
Company’s Health70/100
Valuation 80/100 · PB 1.0137
Technical Avoid
1M -6.454% 6M -10.204% 1Y -25.949%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#196
View details ➜
R
Remedium Lifecare Ltd
Score 48/100• Risky
Remedium Lifecare Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health35/100
Valuation 40/100 · PB 3.0143
Technical Avoid
1M -3.247% 6M -5.063% 1Y -72.763%
Confidence100%
No promoter pledge
High debt/equityThin margins
#197
View details ➜
M
Medistep Healthcare Ltd
Score 48/100• Risky
Medistep Healthcare Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
Company’s Health100/100
Valuation 60/100 · PB 2.409
Technical Avoid
1M -8.875% 6M -43.297% 1Y -43.297%
Confidence100%
Low leverage (D/E)No promoter pledge
#198
View details ➜
M
Medinova Diagnostic Services Ltd
Score 48/100• Risky
Medinova Diagnostic Services Ltd presents a risky investment due to inconsistent growth and market sentiment.
Company’s Health82/100
Valuation 100/100 · PB -32.3679
Technical Avoid
1M -5.426% 6M 3.929% 1Y 1.772%
Confidence100%
No promoter pledgeHealthy profit margins
#199
View details ➜
Z
Zenotech Laboratories Ltd
Score 48/100• Decent
Zenotech Laboratories Ltd shows potential but faces significant challenges in profitability and market sentiment.
Company’s Health79/100
Valuation 40/100 · PB 3.2106
Technical Avoid
1M -7.927% 6M -15.66% 1Y -44.508%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROE
#200
View details ➜
Z
Zenlabs Ethica Ltd
Score 48/100• Risky
Zenlabs Ethica Ltd shows potential but faces significant challenges in growth and profitability, making it a risky investment.
Company’s Health41/100
Valuation 80/100 · PB 1.928
Technical Avoid
1M -10.76% 6M -3.105% 1Y -24.437%
Confidence100%
No promoter pledgeReasonable PB valuation
Weak ROEThin margins
#201
View details ➜
V
Vista Pharmaceuticals Ltd
Score 48/100• Risky
Vista Pharmaceuticals Ltd shows potential but faces significant risks and challenges in growth and profitability.
Company’s Health38/100
Valuation 80/100 · PB 1.2712
Technical Avoid
1M -2.944% 6M -18.435% 1Y -24.9%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#202
View details ➜
V
Vineet Laboratories Ltd
Score 48/100• Risky
Vineet Laboratories Ltd presents a risky investment opportunity due to inconsistent growth and market sentiment.
Company’s Health33/100
Valuation 60/100 · PB 2.5467
Technical Avoid
1M 17.025% 6M 17.954% 1Y -30.007%
Confidence100%
No promoter pledgeReasonable PB valuation
Weak ROEHigh debt/equity
#203
View details ➜
V
Venus Remedies Ltd
Score 48/100• Risky
Venus Remedies Ltd presents a mixed outlook with significant risks overshadowing its potential growth. Investors should exercise caution.
Company’s Health72/100
Valuation 80/100 · PB 1.0997
Technical Avoid
1M -0.199% 6M 48.154% 1Y 32.197%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#204
View details ➜
T
Transgene Biotek Ltd
Score 48/100• Risky
Transgene Biotek Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health46/100
Valuation 60/100 · PB 2.9926
Technical Avoid
1M 18.873% 6M 13.71% 1Y -45.207%
Confidence100%
No promoter pledgeDecent revenue growth
Weak ROEThin margins
#205
View details ➜
S
Supriya Lifescience Ltd
Score 48/100• Decent
Supriya Lifescience Ltd shows potential for growth but faces challenges in profitability and valuation metrics. Caution is advised for new investors.
Company’s Health100/100
Valuation 20/100 · PB 5.8176
Technical Avoid
1M 9.5% 6M -1.699% 1Y 27.828%
Confidence100%
Low leverage (D/E)No promoter pledge
#206
View details ➜
P
Prism Medico and Pharmacy Ltd
Score 48/100• Risky
Prism Medico and Pharmacy Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health39/100
Valuation 100/100 · PB 0.8575
Technical Avoid
1M 29.694% 6M 28.865% 1Y -26.717%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#207
View details ➜
J
JFL Life Sciences Ltd
Score 48/100• Decent
JFL Life Sciences Ltd shows potential in a growing sector, but faces challenges in profitability and market sentiment.
Company’s Health82/100
Valuation 80/100 · PB 1.0452
Technical Avoid
1M -1.916% 6M -40.191% 1Y -46.695%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#208
View details ➜
J
Jeena Sikho Lifecare Ltd
Score 48/100• Risky
Jeena Sikho Lifecare Ltd presents several risks with inconsistent growth and weak profitability metrics, making it a risky investment at this time.
Company’s Health98/100
Valuation 20/100 · PB 33.7978
Technical Avoid
1M -7.952% 6M 60.048% 1Y 138.024%
Confidence100%
Low leverage (D/E)No promoter pledge
#209
View details ➜
S
Syncom Formulations (India) Ltd
Score 48/100• Risky
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health88/100
Valuation 40/100 · PB 4.5003
Technical Avoid
1M -8.375% 6M -6.264% 1Y -22.444%
Confidence100%
Low leverage (D/E)No promoter pledge
#210
View details ➜
Showing 196 to 210 of 301 (21 Pages)